We can tell your molecule’s story
Our mission is to unlock discoveries and develop solutions for biopharmaceutical companies seeking to overcome substantial scientific challenges by providing data of outstanding quality
A powerful, inducible cell system that allows selection of the safest and most efficacious targeted therapies. IndEx-2 is an in vitro cell-based platform that provides inducible expression of any target antigen of interest (TAOI).
IndEx-2 is an effective tool that can be used to enhance a pre-clinical data package with information that offers a more comprehensive understanding of a targeted drug mechanism of action and functional profile.
Read our latest news and browse our scientific resource articles
In this webinar, we present IndEx-2, our powerful in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels.
Explore our SPR research poster which investigates the multi-specific modalities of immunotherapeutic molecules.
Antibody Analytics has secured a multi-million-pound investment from NorthEdge. Read on to find out more details.
Explore our research poster as we analyse the data from our new cell line development platform, IndEx-2.